“ Looking at our productivity in 2017 alone, which includes three new therapy approvals, it is clear that the model we established makes good sense ”
In Conversation
“ "Serbia really has a huge potential especially in the innovation and technology sectors, but current developments in these areas are still modest." ”
Interview: Florentino Cardoso – President, Associação Médica Brasileira (Brazilian Medical Association)
“ "As for healthcare management, we have to ensure that people shaping new healthcare policies in the country are well educated from technical and scientific standpoints and… ”
“ "Apollo Telemedicine is working very closely with different state governments and providing telemedicine solutions to a large section of people who do not have access to… ”
“ "Our main competitive advantage on international markets relates to the proven quality of the pharmaceutical products developed and manufactured in Brazil." ”
“ "Canada has always been known for our great research, but an area where Canada is lagging behind significantly is the commercialization of products." ”
Interview: Alexander Biach – Chairman, Hauptverband (Main Association of Austrian Social Security Institutions)
“ "We have the highest coverage of citizens of any country in Europe, which has been highlighted by studies by the OECD and the London School of… ”
“ "The ultimate goal of our investment is to license the production and commercialization of our products to pharmaceutical companies." ”
“ "Serbia has such agreements and tax laws with the EU allowing us to import and export goods without paying customs." ”
“ "Phytobios is responsible for the tough task of organising the expeditions to the Amazon and Atlantic forest and also to the Brazilian savannah for data and… ”
Interview: Gintautas Barcys – Director, State Medicines Control Agency (SMCA), Ministry of Health, Lithuania
“ "Expanding on other interesting trends, it is a reality that more and more companies are willing to launch their products to the Baltic region and Lithuania,… ”
“ "We want stakeholders to know that we are a leading company in diabetes – this is the core of our business." ”